SARS-CoV-2 Omicron BA.1/BA.2 Neutralization up to 8 Weeks After PrEP With Sotrovimab or Cilgavimab/Tixagevimab

Transpl Int. 2022 Dec 12:35:10906. doi: 10.3389/ti.2022.10906. eCollection 2022.

Authors

Karin Stiasny¹, Lukas Weseslindtner¹, Andreas Heinzel², Jeremy V Camp¹, Rainer Oberbauer², Roman Reindl-Schwaighofer²

Affiliations

¹ Center of Virology, Medical University of Vienna, Vienna, Austria.
² Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

No abstract available

Keywords: COVID-19; SARS-CoV2; antiviral; kidney transplantation; prophylaxis.

MeSH terms

Antibodies, Viral
COVID-19*
Humans
SARS-CoV-2*

Substances

cilgavimab
sotrovimab
tixagevimab
Antibodies, Viral